-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Regenerx Biopharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q1 2023.
- Regenerx Biopharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$80.3K, a 0.08% decline year-over-year.
- Regenerx Biopharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$326K, a 20.9% decline year-over-year.
- Regenerx Biopharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was -$325K, a 20.9% decline from 2021.
- Regenerx Biopharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was -$269K, a 17.7% decline from 2020.
- Regenerx Biopharmaceuticals Inc annual Nonoperating Income (Expense) for 2020 was -$229K, a 60.7% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)